Total Return Level Chart

View Total Return Level for AXSM.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Total Return Level Chart
Start Trial

Historical Total Return Level Data

View and export this data back to 2015. Start Trial.
Date Value
September 15, 2026 204.07
September 14, 2026 216.58
September 11, 2026 220.75
September 10, 2026 211.12
September 09, 2026 210.63
September 08, 2026 207.82
September 04, 2026 206.68
September 03, 2026 208.35
September 02, 2026 209.92
September 01, 2026 202.83
August 31, 2026 198.52
August 28, 2026 199.02
August 27, 2026 206.27
August 26, 2026 207.15
August 25, 2026 205.48
August 24, 2026 205.40
August 21, 2026 207.77
August 20, 2026 208.03
August 19, 2026 218.20
August 18, 2026 215.69
August 17, 2026 216.27
August 14, 2026 213.67
August 13, 2026 213.68
August 12, 2026 214.66
August 11, 2026 215.77
Date Value
August 10, 2026 220.89
August 07, 2026 212.74
August 06, 2026 210.13
August 05, 2026 212.85
August 04, 2026 212.17
August 03, 2026 211.04
July 31, 2026 217.99
July 30, 2026 234.64
July 29, 2026 227.42
July 28, 2026 234.20
July 27, 2026 238.37
July 24, 2026 241.00
July 23, 2026 241.53
July 22, 2026 239.62
July 21, 2026 236.95
July 20, 2026 221.64
July 17, 2026 230.00
July 16, 2026 237.04
July 15, 2026 237.53
July 14, 2026 235.26
July 13, 2026 228.28
July 10, 2026 233.80
July 09, 2026 248.95
July 08, 2026 245.57
July 07, 2026 249.76

Total Return Level Definition

The total return level allows investors to view the performance of a security inclusive of both price appreciation and dividends/distributions. Total return level is seen as the most accurate calculation that produces returns consistent with most other sources.

Read full definition.

Total Return Level Range, Past 5 Years

View Total Return Level Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Total Return Level Benchmarks

View Total Return Level Benchmarks
Start Trial
Eli Lilly & Co. 3001.84
Liquidia Corp. 65.72
Filana Therapeutics, Inc. 0.9082
CorMedix, Inc. 7.76
Eloxx Pharmaceuticals, Inc. 18.25